THE INFLAMMATORY BREAST CANCER NETWORK UK
Provision of support for individuals affected by Inflammatory Breast Cancer, education about this rare disease and support for research into Inflammatory Breast Cancer.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net surplus of £63,902 for the year ended 5 April 2025, with unrestricted cash funds standing at £95,910. The trustees note that the charity employs no staff and has low day-to-day operating requirements, maintaining reserves of £95,910 which exceed the adopted policy target of £6,000. The financial position is described as stable, with the board satisfied that adequate resources exist to continue operations for the foreseeable future.
What the accounts disclose
“this was amended to £6,000. This updated policy as at 5 April 2025 is met.”
Trustees
- Ashleigh Williams
- Becky Wright
- Dr Richard Amos
- Lucy Reynolds
- Melanie Jane Truby Crooks
- Naomi John
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 05/04/2025 | £78k | £14k |
| 31/03/2024 | £80k | £79k |
| 05/04/2023 | £62k | £83k |
| 05/04/2022 | £70k | £56k |
| 05/04/2021 | £34k | £41k |
Common questions
Is THE INFLAMMATORY BREAST CANCER NETWORK UK financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net surplus of £63,902 for the year ended 5 April 2025, with unrestricted cash funds standing at £95,910. The trustees note that the charity employs no staff and has low day-to-day operating requirements, maintaining reserves of £95,910 which exceed the adopted policy target of £6,000. The financial position is described as stable, with the board satisfied that adequate resources exist to continue operations for the foreseeable future. Its FY2025 accounts were independently examined.